CDK1 and neoplasm: Additionally, Western blot analysis of tumor tissue indicated that 50 mg/kg cyclobrachycoumarin decreased the expressions of CDK1, total PARP, and survivin while enhancing cleaved PARP levels in vivo (Figure 5g,h).